Search

Your search keyword '"Alvares-Da-Silva, Mario R."' showing total 124 results

Search Constraints

Start Over You searched for: Author "Alvares-Da-Silva, Mario R." Remove constraint Author: "Alvares-Da-Silva, Mario R."
124 results on '"Alvares-Da-Silva, Mario R."'

Search Results

1. Low hepatic artery resistive index on Doppler ultrasound performed on the first post-liver transplant day is associated both with hepatic artery thrombosis and decreased graft survival

4. Liver transplantation in Latin America: reality and challenges

5. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

6. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

10. Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Nonrecyclable Waste

11. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

12. Celiac trunk stenosis by median arcuate ligament in orthotopic liver transplantation: a potential hidden foe to the biliary tree

13. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis

18. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

22. Low hepatic artery resistive index on the first post-transplant day is associated with inferior graft survival in adult liver transplantation

23. Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study

24. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

26. Global multi-stakeholder endorsement of the MAFLD definition

27. Global multi-stakeholder endorsement of the MAFLD definition

28. Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

30. Potentially hepatotoxic drugs are still being prescribed to liver disease patients under tertiary care: it is time to say enough

31. WGO guidance for the care of patients with COVID-19 and liver disease

32. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease

33. Author Correction: Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data

34. International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

36. High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?

38. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients

40. Liver Transplantation Utilizing Mixed Biologic and Synthetic Arterial Conduits

41. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients

42. Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma

45. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology

46. Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma.

49. Physical training improves body weight and energy balance but does not protect against hepatic steatosis in obese mice

Catalog

Books, media, physical & digital resources